Moderna
MRNA
#1352
Rank
โ‚ฌ12.74 B
Marketcap
33,12ย โ‚ฌ
Share price
0.89%
Change (1 day)
-64.73%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ12.74 Billion

As of January 2025 Moderna has a market cap of โ‚ฌ12.74 Billion. This makes Moderna the world's 1352th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ12.74 B-14.13%
2024โ‚ฌ14.84 B-56.74%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Moderna was reported to be:

โ‚ฌ12.63 Billion
by Yahoo Finance info icon info icon
โ‚ฌ12.63 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ12.63 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ78.97 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ240.84 B 1,789.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.81 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.88 B 142.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ192.37 B 1,409.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.36 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ344.18 B 2,600.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.89 B-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA